Skip to main content
. 2020 Sep 18;8:e9965. doi: 10.7717/peerj.9965

Table 1. Drug-candidates clustered by fingerprint similarity–overlap alignment.

Cluster
A B C D E F G
Alclometasone Abemaciclib Bilastine Dipyridamole Acebutolol Isoetharine Lactulose
alpha-Tocopherol acetate Bosentan Darifenacin Enoxacin Atenolol Isoxsuprine Micronomicin
Bimatoprost Cefdinir Droperidol Gatifloxacin Betaxolol Nylidrin Netilmicin
Boceprevir Cefmenoxime Fluspirilene Gemifloxacin Bisoprolol Protokylol Tobramycin
Buprenorphine Cefmetazole Haloperidol Moxifloxacin Celiprolol
Calcitriol Cefotaxime Iloperidone Esmolol
Diflorasone Cefotiam Loperamide Metipranolol
Dihydroergocryptine Cephaloglycin Ropinirole Metoprolol
Flunisolide Copanlisib Ziprasidone Nadolol
Fluocinolone acetonide Dasatinib Propafenone
Ibutilide Dicloxacillin
Iloprost Doxazosin
Lapyrium Enasidenib
Lovastatin Flucloxacillin
Methyl undecenoyl leucinate Gefitinib
Retapamulin Latamoxef
Ritonavir Nilotinib
Travoprost Prazosin
Vitamin E Succinate Riociguat
Zucapsaicin Vemurafenib